4 weeks CAH Q2 Earnings and Sales Beat Estimates, 2025 EPS View Raised Zacks

Cardinal Health’s second-quarter fiscal 2025 results benefit from solid Other segment revenue growth. However, OptumRx contract expiry hurts Pharmaceutical segment sales.